{
  "civic.tid:15": {
    "id": "civic.tid:15",
    "label": "Erlotinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:337525"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:648",
              "type": "Disease",
              "label": "Pancreatic cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C43298"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C65530"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:4": {
    "id": "civic.tid:4",
    "label": "Vemurafenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1147220"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:629",
              "type": "Disease",
              "label": "Melanoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3224"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:594",
              "type": "Disease",
              "label": "Erdheim-Chester disease",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C53972"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C64768"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
      "BRAF (V600E) Kinase Inhibitor RO5185426",
      "BRAF(V600E) Kinase Inhibitor RO5185426",
      "PLX-4032",
      "PLX4032",
      "RG 7204",
      "RG7204",
      "RO 5185426",
      "Zelboraf"
    ]
  },
  "civic.tid:187": {
    "id": "civic.tid:187",
    "label": "Osimertinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1721560"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C116377"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-",
      "AZD-9291",
      "AZD9291",
      "Mereletinib",
      "Tagrisso"
    ]
  },
  "civic.tid:146": {
    "id": "civic.tid:146",
    "label": "Afatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1430438"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:25316",
              "type": "Disease",
              "label": "Non-small cell lung cancer squamous"
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C66940"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(2e)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3s)-Oxolan-3-yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)But-2-Enamide",
      "BIBW 2992",
      "BIBW2992"
    ]
  },
  "civic.tid:654": {
    "id": "civic.tid:654",
    "label": "Sotorasib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2550714"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C154287"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AMG 510",
      "AMG-510",
      "AMG510",
      "Lumakras"
    ]
  },
  "civic.tid:22": {
    "id": "civic.tid:22",
    "label": "Dabrafenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1424911"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:629",
              "type": "Disease",
              "label": "Melanoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3224"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:675",
              "type": "Disease",
              "label": "Thyroid cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7510"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C82386"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "BRAF Inhibitor GSK2118436",
      "Benzenesulfonamide, N-(3-(5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluoro-",
      "GSK-2118436",
      "GSK-2118436A",
      "GSK2118436"
    ]
  },
  "civic.tid:16": {
    "id": "civic.tid:16",
    "label": "Cetuximab",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:318341"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D015179",
              "type": "Disease",
              "label": "Colorectal Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2956"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D006258",
              "type": "Disease",
              "label": "Head and Neck Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4013"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D002294",
              "type": "Disease",
              "label": "Carcinoma, Squamous Cell",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2929"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1723"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Cetuximab Biosimilar CDP-1",
      "Cetuximab Biosimilar CMAB009",
      "Cetuximab Biosimilar KL 140",
      "Chimeric Anti-EGFR Monoclonal Antibody",
      "Chimeric MoAb C225",
      "Chimeric Monoclonal Antibody C225",
      "Erbitux",
      "IMC-C225"
    ]
  },
  "civic.tid:44": {
    "id": "civic.tid:44",
    "label": "Dacomitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2058848"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C53398"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(2E)-N-(4-((3-Chloro-4-Fluorophenyl)Amino)-7-Methoxyquinazolin-6-yl)-4-Piperidin-1-ylbut-2-Enamide",
      "EGFR Inhibitor PF-00299804",
      "PF-00299804",
      "PF-00299804-03",
      "PF-299804",
      "Vizimpro"
    ]
  },
  "civic.tid:5": {
    "id": "civic.tid:5",
    "label": "Imatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:282388"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:669",
              "type": "Disease",
              "label": "Systemic mastocytosis",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9235"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:634",
              "type": "Disease",
              "label": "Myelodysplastic syndrome",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3247"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:602",
              "type": "Disease",
              "label": "Gastrointestinal stromal tumor",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3868"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:33893",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia pediatric"
            },
            {
              "id": "hemonc:667",
              "type": "Disease",
              "label": "Soft tissue sarcoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9306"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:616",
              "type": "Disease",
              "label": "Hypereosinophilic syndrome",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C27038"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C62035"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
    ]
  },
  "civic.tid:24385": {
    "id": "civic.tid:24385",
    "label": "Peginterferon Alfa-2b",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:253453"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D008545",
              "type": "Disease",
              "label": "Melanoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3224"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D019698",
              "type": "Disease",
              "label": "Hepatitis C, Chronic",
              "mappings": [
                {
                  "coding": {
                    "system": "mondo",
                    "code": "0005354"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1845"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "PEG Interferon Alpha-2b",
      "PEG Intron",
      "PEG-IFN Alfa-2b",
      "PEG-IFN-a 2b",
      "PEG-Interferon Alfa-2b",
      "PEG-Intron",
      "Pegylated Interferon Alpha-2b",
      "Polyethylene Glycol IFN-A2b",
      "Polyethylene Glycol Interferon Alfa-2b",
      "SCH 54031",
      "Sylatron"
    ]
  },
  "civic.tid:227": {
    "id": "civic.tid:227",
    "label": "Ibrutinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1442981"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:682",
              "type": "Disease",
              "label": "Waldenstroem macroglobulinemia"
            },
            {
              "id": "hemonc:605",
              "type": "Disease",
              "label": "Graft versus host disease",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3063"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:581",
              "type": "Disease",
              "label": "Chronic lymphocytic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3163"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:625",
              "type": "Disease",
              "label": "Mantle cell lymphoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4337"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:626",
              "type": "Disease",
              "label": "Marginal zone lymphoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4341"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C81934"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-",
      "BTK Inhibitor PCI-32765",
      "CRA-032765",
      "Imbruvica",
      "PCI-32765"
    ]
  },
  "civic.tid:91": {
    "id": "civic.tid:91",
    "label": "Rociletinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C99905"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C99905"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "CO-1686",
      "N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide"
    ]
  },
  "civic.tid:326": {
    "id": "civic.tid:326",
    "label": "Cisplatin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2555"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:671",
              "type": "Disease",
              "label": "Testicular cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C5053"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:569",
              "type": "Disease",
              "label": "Bladder cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9334"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C376"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(SP-4-2)-Diamminedichloroplatinum",
      "Abiplatin",
      "Blastolem",
      "Briplatin",
      "CDDP",
      "Cis-diammine-dichloroplatinum",
      "Cis-diamminedichloridoplatinum",
      "Cis-diamminedichloro Platinum (II)",
      "Cis-diamminedichloroplatinum",
      "Cis-dichloroammine Platinum (II)",
      "Cis-platinous Diamine Dichloride",
      "Cis-platinum",
      "Cis-platinum II",
      "Cis-platinum II Diamine Dichloride",
      "Cismaplat",
      "Cisplatina",
      "Cisplatinum",
      "Cisplatyl",
      "Citoplatino",
      "Citosin",
      "Cysplatyna",
      "DDP",
      "Lederplatin",
      "Metaplatin",
      "Neoplatin",
      "Peyrone's Chloride",
      "Peyrone's Salt",
      "Placis",
      "Plastistil",
      "Platamine",
      "Platiblastin",
      "Platiblastin-S",
      "Platinex",
      "Platinol",
      "Platinol- AQ",
      "Platinol-AQ",
      "Platinol-AQ VHA Plus",
      "Platinoxan",
      "Platinum",
      "Platinum Diamminodichloride",
      "Platinum, Diaminedichloro-, Cis- (8CI)",
      "Platiran",
      "Platistin",
      "Platosin"
    ]
  },
  "civic.tid:84": {
    "id": "civic.tid:84",
    "label": "Trastuzumab",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2103478"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D001943",
              "type": "Disease",
              "label": "Breast Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2910"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1647"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ABP 980",
      "ALT02",
      "Anti-ERB-2",
      "Anti-HER2/c-erbB2 Monoclonal Antibody",
      "Anti-c-ERB-2",
      "Anti-c-erbB2 Monoclonal Antibody",
      "Anti-erbB-2",
      "Anti-erbB2 Monoclonal Antibody",
      "Anti-p185-HER2",
      "C-erb-2 Monoclonal Antibody",
      "HER2 Monoclonal Antibody",
      "Herceptin",
      "Herceptin Biosimilar PF-05280014",
      "Herceptin Trastuzumab Biosimilar PF-05280014",
      "Herzuma",
      "Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman P185(Sup C-erbB2) Receptor), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer",
      "Kanjinti",
      "MoAb HER2",
      "Monoclonal Antibody C-erb-2",
      "Monoclonal Antibody HER2",
      "Ogivri",
      "Ontruzant",
      "PF-05280014",
      "RO0452317",
      "RhuMAb HER2",
      "SB3",
      "Trastuzumab Biosimilar ABP 980",
      "Trastuzumab Biosimilar ALT02",
      "Trastuzumab Biosimilar EG12014",
      "Trastuzumab Biosimilar HLX02",
      "Trastuzumab Biosimilar PF-05280014",
      "Trastuzumab Biosimilar SB3",
      "Trastuzumab Biosimilar SIBP-01",
      "Trastuzumab-anns",
      "Trastuzumab-dkst",
      "Trastuzumab-dttb",
      "Trastuzumab-pkrb",
      "Trastuzumab-qyyp",
      "Trazimera"
    ]
  },
  "civic.tid:323": {
    "id": "civic.tid:323",
    "label": "Midostaurin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1919083"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:669",
              "type": "Disease",
              "label": "Systemic mastocytosis",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9235"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1872"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "CGP 41251",
      "CGP41251",
      "N-Benzoyl-Staurosporine",
      "N-Benzoylstaurosporine",
      "PKC-412",
      "PKC412",
      "Rydapt"
    ]
  },
  "civic.tid:420": {
    "id": "civic.tid:420",
    "label": "Fluorouracil",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:4492"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C505"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2,4-Dioxo-5-fluoropyrimidine",
      "5 FU",
      "5 Fluorouracil",
      "5 Fluorouracilum",
      "5-FU",
      "5-Fluoro-2,4(1H, 3H)-pyrimidinedione",
      "5-Fluoro-2,4(1H,3H)-pyrimidinedione",
      "5-Fluorouracil",
      "5-Fluracil",
      "5FU",
      "AccuSite",
      "Adrucil",
      "Carac",
      "Fluoro Uracil",
      "Fluouracil",
      "Flurablastin",
      "Fluracedyl",
      "Fluracil",
      "Fluril",
      "Fluroblastin",
      "Ribofluor",
      "Ro 2-9757",
      "Ro-2-9757"
    ]
  },
  "civic.tid:19": {
    "id": "civic.tid:19",
    "label": "Trametinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1425098"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C77908"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GSK1120212",
      "JTP-74057",
      "MEK Inhibitor GSK1120212",
      "Mekinist",
      "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
    ]
  },
  "civic.tid:14": {
    "id": "civic.tid:14",
    "label": "Gefitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:328134"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1855"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline",
      "Iressa",
      "N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) Propoxy]-4-quinazolinamine",
      "ZD 1839",
      "ZD1839"
    ]
  },
  "civic.tid:112": {
    "id": "civic.tid:112",
    "label": "Capivasertib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C102564"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C102564"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD5363"
    ]
  },
  "civic.tid:696": {
    "id": "civic.tid:696",
    "label": "Akt/ERK Inhibitor ONC201",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C113792"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C113792"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ONC-201",
      "ONC201",
      "TIC10"
    ]
  },
  "civic.tid:144": {
    "id": "civic.tid:144",
    "label": "Cabozantinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1363267"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:65823",
              "type": "Disease",
              "label": "Thyroid cancer differentiated"
            },
            {
              "id": "hemonc:660",
              "type": "Disease",
              "label": "Renal cell carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9385"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:612",
              "type": "Disease",
              "label": "Hepatocellular carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3099"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:68942",
              "type": "Disease",
              "label": "Thyroid cancer medullary"
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C52200"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- Fluorophenyl)-",
      "N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- Dicarboxamide"
    ]
  },
  "civic.tid:27": {
    "id": "civic.tid:27",
    "label": "Regorafenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1312397"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D015179",
              "type": "Disease",
              "label": "Colorectal Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2956"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C78204"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide",
      "BAY 73-4506",
      "REGORAFENIB ANHYDROUS",
      "Stivarga"
    ]
  },
  "civic.tid:157": {
    "id": "civic.tid:157",
    "label": "Sunitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:357977"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:647",
              "type": "Disease",
              "label": "Pancreatic NET",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C27720"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:602",
              "type": "Disease",
              "label": "Gastrointestinal stromal tumor",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3868"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:660",
              "type": "Disease",
              "label": "Renal cell carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9385"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C71622"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
    ]
  },
  "civic.tid:81": {
    "id": "civic.tid:81",
    "label": "Paclitaxel",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:56946"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:54036",
              "type": "Disease",
              "label": "Kaposi sarcoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9087"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1411"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5Beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one, 4,10-Diacetate 2-Benzoate 13-Ester With (2R,3S)-N-Benzoyl-3-phenylisoserine",
      "Anzatax",
      "Asotax",
      "Bristaxol",
      "Praxel",
      "Taxol",
      "Taxol Konzentrat",
      "[2aR-[2a Alpha,4beta,4a Beta,6beta,9alpha(alphaR*,betaS*),-11alpha,12alpha,12a Alpha,12b Alpha]]-beta-(benzoylamino)-alpha-hydroxybenzene-propanoic Acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-1a,33,4,-41,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-41,8,-12,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester"
    ]
  },
  "civic.tid:6": {
    "id": "civic.tid:6",
    "label": "Sorafenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:495881"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:65823",
              "type": "Disease",
              "label": "Thyroid cancer differentiated"
            },
            {
              "id": "hemonc:612",
              "type": "Disease",
              "label": "Hepatocellular carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3099"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:660",
              "type": "Disease",
              "label": "Renal cell carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9385"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C61948"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "BA4 43 9006",
      "BAY 43-9006",
      "Bay-439006"
    ]
  },
  "civic.tid:237": {
    "id": "civic.tid:237",
    "label": "Oxaliplatin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:32592"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:46096",
              "type": "Disease",
              "label": "Colorectal cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4978"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:585",
              "type": "Disease",
              "label": "Colon cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9242"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1181"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1-OHP",
      "Ai Heng",
      "Aiheng",
      "DACPLAT",
      "Dacotin",
      "Diaminocyclohexane Oxalatoplatinum",
      "ELOXATIN",
      "Eloxatine",
      "JM-83",
      "Oxalato (1R,2R-cyclohexanediamine)platinum(II)",
      "Oxalato (trans-l-1,2-diaminocyclohexane)platinum(II)",
      "Oxalatoplatin",
      "Oxalatoplatinum",
      "RP 54780",
      "RP-54780",
      "SR-96669",
      "Trans-l DACH Oxalatoplatinum",
      "Trans-l Diaminocyclohexane Oxalatoplatinum",
      "[(1R,-2R)-1,2-cyclohexanediamine-N,N'][oxalato (2--)-O,O']platinum",
      "[SP-4-2-(1R-trans)]-(1,2,cyclohexanediamine-N,N')[ethanedioato(2--)-O,O']platinum"
    ]
  },
  "civic.tid:101": {
    "id": "civic.tid:101",
    "label": "Irinotecan",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:153329"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:46096",
              "type": "Disease",
              "label": "Colorectal cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4978"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C62040"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione",
      "(+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate",
      "7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin",
      "[1,4'-bipiperidine]-1'-carboxylic Acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester"
    ]
  },
  "civic.tid:243": {
    "id": "civic.tid:243",
    "label": "MEK Inhibitor RO4987655",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C82696"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C82696"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "RO-4987655",
      "RO4987655"
    ]
  },
  "civic.tid:328": {
    "id": "civic.tid:328",
    "label": "Melphalan",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:6718"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:633",
              "type": "Disease",
              "label": "Multiple myeloma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3242"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C633"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-[bis(2-chloroethyl)amino]-L-phenylalanine",
      "Alanine Nitrogen Mustard",
      "CB-3025",
      "L-PAM",
      "L-Phenylalanine Mustard",
      "L-Sarcolysin",
      "L-Sarcolysin Phenylalanine Mustard",
      "L-Sarcolysine",
      "Melphalanum",
      "P-di(chloroethyl)amino-L-phenylalanine",
      "Phenylalanine Mustard",
      "Phenylalanine Nitrogen Mustard",
      "Sarcoclorin",
      "Sarkolysin",
      "WR-19813"
    ]
  },
  "civic.tid:11": {
    "id": "civic.tid:11",
    "label": "Temozolomide",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:37776"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:604",
              "type": "Disease",
              "label": "Glioblastoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3058"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:559",
              "type": "Disease",
              "label": "Anaplastic glioma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C127816"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1244"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide",
      "8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one",
      "CCRG-81045",
      "Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-",
      "M & B 39831",
      "M And B 39831",
      "Methazolastone",
      "RP-46161",
      "SCH 52365",
      "TMZ",
      "Temcad",
      "Temodal",
      "Temodar",
      "Temomedac"
    ]
  },
  "civic.tid:454": {
    "id": "civic.tid:454",
    "label": "Ivosidenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2049873"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:580",
              "type": "Disease",
              "label": "Cholangiocarcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4436"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C114383"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AG-120",
      "Tibsovo"
    ]
  },
  "civic.tid:537": {
    "id": "civic.tid:537",
    "label": "Imatinib Mesylate",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:282388"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:669",
              "type": "Disease",
              "label": "Systemic mastocytosis",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9235"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:634",
              "type": "Disease",
              "label": "Myelodysplastic syndrome",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3247"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:602",
              "type": "Disease",
              "label": "Gastrointestinal stromal tumor",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3868"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:33893",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia pediatric"
            },
            {
              "id": "hemonc:667",
              "type": "Disease",
              "label": "Soft tissue sarcoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9306"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:616",
              "type": "Disease",
              "label": "Hypereosinophilic syndrome",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C27038"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1687"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Monomethanesulfonate",
      "CGP 57148",
      "CGP57148B",
      "Gleevec",
      "Glivec",
      "STI 571",
      "STI-571",
      "STI571"
    ]
  },
  "civic.tid:28": {
    "id": "civic.tid:28",
    "label": "Panitumumab",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:263034"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D015179",
              "type": "Disease",
              "label": "Colorectal Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2956"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1857"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ABX-EGF",
      "ABX-EGF Monoclonal Antibody",
      "ABX-EGF, Clone E7.6.3",
      "E7.6.3",
      "Human IgG2K Monoclonal Antibody",
      "MoAb ABX-EGF",
      "MoAb E7.6.3",
      "Monoclonal Antibody ABX-EGF",
      "Monoclonal Antibody E7.6.3",
      "Vectibix"
    ]
  },
  "civic.tid:431": {
    "id": "civic.tid:431",
    "label": "Rucaparib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1862579"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C137800"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-Fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-",
      "8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one"
    ]
  },
  "civic.tid:20": {
    "id": "civic.tid:20",
    "label": "Dasatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1546019"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C38713"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate",
      "BMS-354825",
      "Dasatinib Hydrate",
      "Dasatinib Monohydrate",
      "Sprycel"
    ]
  },
  "civic.tid:190": {
    "id": "civic.tid:190",
    "label": "Vismodegib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1242987"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:587",
              "type": "Disease",
              "label": "Cutaneous basal cell carcinoma"
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C74038"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide",
      "Erivedge",
      "GDC-0449",
      "Hedgehog Antagonist GDC-0449"
    ]
  },
  "civic.tid:138": {
    "id": "civic.tid:138",
    "label": "Pembrolizumab",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1547545"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D008545",
              "type": "Disease",
              "label": "Melanoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3224"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C106432"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Immunoglobulin G4, Anti-(Human Programmed Cell Death 1); Humanized Mouse Monoclonal (228-L-proline(H10-S>P))gamma 4 Heavy Chain (134-218')-disulfide With Humanized Mouse Monoclonal Kappa Light Chain Dimer (226-226'':229-229'')-bisdisulfide",
      "Keytruda",
      "Lambrolizumab",
      "MK-3475",
      "SCH 900475"
    ]
  },
  "civic.tid:41": {
    "id": "civic.tid:41",
    "label": "Everolimus",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:141704"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:641",
              "type": "Disease",
              "label": "Neuroendocrine tumor",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3809"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:647",
              "type": "Disease",
              "label": "Pancreatic NET",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C27720"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:660",
              "type": "Disease",
              "label": "Renal cell carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9385"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:45070",
              "type": "Disease",
              "label": "Subependymal giant cell astrocytoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3696"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C48387"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone",
      "42-O-(2-Hydroxy)ethyl Rapamycin",
      "Afinitor",
      "Certican",
      "RAD 001",
      "RAD001",
      "Votubia",
      "Zortress"
    ]
  },
  "civic.tid:386": {
    "id": "civic.tid:386",
    "label": "Ruxolitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1193326"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:605",
              "type": "Disease",
              "label": "Graft versus host disease",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3063"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:655",
              "type": "Disease",
              "label": "Polycythemia vera",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3336"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:635",
              "type": "Disease",
              "label": "Myelofibrosis",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3248"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C77888"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile",
      "INCB-18424",
      "INCB18424",
      "Jakafi",
      "Oral JAK Inhibitor INCB18424"
    ]
  },
  "civic.tid:63": {
    "id": "civic.tid:63",
    "label": "Selumetinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2289380"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C66939"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ARRY-142886",
      "AZD6244",
      "MEK Inhibitor AZD6244"
    ]
  },
  "civic.tid:425": {
    "id": "civic.tid:425",
    "label": "Savolitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C104732"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C104732"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD 6094",
      "AZD6094",
      "HMPL-504",
      "Volitinib"
    ]
  },
  "civic.tid:159": {
    "id": "civic.tid:159",
    "label": "Ceritinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1535457"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C115112"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-",
      "LDK 378",
      "LDK378",
      "Zykadia"
    ]
  },
  "civic.tid:42": {
    "id": "civic.tid:42",
    "label": "Olaparib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1597582"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:648",
              "type": "Disease",
              "label": "Pancreatic cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C43298"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:658",
              "type": "Disease",
              "label": "Prostate cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7378"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C71721"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD 2281",
      "AZD-2281",
      "AZD2281",
      "KU-0059436",
      "Lynparza",
      "PARP Inhibitor AZD2281"
    ]
  },
  "civic.tid:145": {
    "id": "civic.tid:145",
    "label": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C2167"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C2167"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:120": {
    "id": "civic.tid:120",
    "label": "Idelalisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1544460"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:599",
              "type": "Disease",
              "label": "Follicular lymphoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3209"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:581",
              "type": "Disease",
              "label": "Chronic lymphocytic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3163"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C78825"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H- Quinazolin-4-one",
      "CAL-101",
      "GS 1101",
      "GS-1101",
      "Phosphoinositide-3 Kinase Delta Inhibitor CAL-101",
      "Zydelig"
    ]
  },
  "civic.tid:12": {
    "id": "civic.tid:12",
    "label": "Crizotinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1148495"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:25958",
              "type": "Disease",
              "label": "Anaplastic large cell lymphoma pediatric"
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C74061"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(R)-3-(1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(Piperidin-4-Yl)-1h-Pyrazol-4-Yl)Pyridin-2-Amine",
      "2-Pyridinamine, 3-((1R)-1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(4-Piperidinyl)-1H-Pyrazol-4-yl)-",
      "MET Tyrosine Kinase Inhibitor PF-02341066",
      "PF-02341066",
      "PF-2341066",
      "Xalkori"
    ]
  },
  "civic.tid:350": {
    "id": "civic.tid:350",
    "label": "MEK Inhibitor TAK-733",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C84858"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C84858"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "TAK-733"
    ]
  },
  "civic.tid:685": {
    "id": "civic.tid:685",
    "label": "Therapeutic Tumor Infiltrating Lymphocytes",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C28699"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C28699"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Tumor Infiltrating Lymphocyte Therapy",
      "Tumor Infiltrating Lymphocytes"
    ]
  },
  "civic.tid:426": {
    "id": "civic.tid:426",
    "label": "Entrectinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2197862"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C114984"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",
      "RXDX 101",
      "RXDX-101",
      "RXDX101",
      "Rozlytrek"
    ]
  },
  "civic.tid:601": {
    "id": "civic.tid:601",
    "label": "Selpercatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2370147"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:675",
              "type": "Disease",
              "label": "Thyroid cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7510"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C134987"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitril",
      "LOXO-292",
      "RET Inhibitor LOXO-292",
      "RET Kinase Inhibitor LOXO-292",
      "Retevmo",
      "WHO 10967"
    ]
  },
  "civic.tid:56": {
    "id": "civic.tid:56",
    "label": "Pazopanib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:714438"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C74547"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-",
      "GW786034"
    ]
  },
  "civic.tid:1975": {
    "id": "civic.tid:1975",
    "label": "Pemigatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2359268"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:580",
              "type": "Disease",
              "label": "Cholangiocarcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4436"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C121553"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2H-Pyrrolo(3',2':5,6)pyrido(4,3-d)pyrimidin-2-one, 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-8-(4-morpholinylmethyl)-",
      "INCB054828",
      "Pemazyre"
    ]
  },
  "civic.tid:10": {
    "id": "civic.tid:10",
    "label": "Tanespimycin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C37899"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C37899"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "17-(Allylamino)-17-demethoxygeldanamycin",
      "17-AAG",
      "17-Allylamino-17-demethoxygeldanamycin",
      "17-Demethoxy-17-(2-propenylamino)geldanamycin",
      "17-N-allylamino-17-demethoxy Geldanamycin",
      "17-N-allylamino-17-demethoxygeldanamycin",
      "Geldanamycin, 17-allylamino-17-demethoxy-",
      "KOS-953"
    ]
  },
  "civic.tid:141": {
    "id": "civic.tid:141",
    "label": "Pictilisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C165479"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:148": {
    "id": "civic.tid:148",
    "label": "Abemaciclib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1946825"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C97660"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)",
      "LY-2835219",
      "LY2835219",
      "Verzenio"
    ]
  },
  "civic.tid:43": {
    "id": "civic.tid:43",
    "label": "Akt Inhibitor MK2206",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C90581"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C90581"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1,2,4-Triazolo(3,4-f)(1,6)naphthyridin-3(2H)-one, 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-",
      "MK 2206",
      "MK-2206",
      "MK-2206 FREE BASE",
      "MK2206"
    ]
  },
  "civic.tid:377": {
    "id": "civic.tid:377",
    "label": "Apitolisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C91731"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C91731"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GDC 0980",
      "GDC-0980",
      "GNE 390",
      "RG 7422"
    ]
  },
  "civic.tid:572": {
    "id": "civic.tid:572",
    "label": "Meloxicam",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:41493"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C61439"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide",
      "Mobec",
      "Mobic",
      "Mobicox",
      "Movalis",
      "Movatec"
    ]
  },
  "civic.tid:574": {
    "id": "civic.tid:574",
    "label": "Venetoclax",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1747556"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:581",
              "type": "Disease",
              "label": "Chronic lymphocytic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3163"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C103147"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-(4-((2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide",
      "ABT-0199",
      "ABT-199",
      "ABT199",
      "GDC-0199",
      "RG7601",
      "Venclexta",
      "Venclyxto"
    ]
  },
  "civic.tid:411": {
    "id": "civic.tid:411",
    "label": "Tazemetostat",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2274378"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C107506"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "E7438",
      "EPZ-6438",
      "EPZ6438",
      "N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide",
      "N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide"
    ]
  },
  "civic.tid:573": {
    "id": "civic.tid:573",
    "label": "Larotrectinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2105628"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:44382",
              "type": "Disease",
              "label": "Malignant solid neoplasm",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C132146"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C115977"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-",
      "3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide",
      "ARRY 470",
      "LOXO 101",
      "LOXO-101"
    ]
  },
  "civic.tid:520": {
    "id": "civic.tid:520",
    "label": "Bosutinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1307619"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "EFO:0000339",
              "type": "Disease",
              "label": "chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C60809"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-Anilino-3-quinolinecarbonitrile",
      "4-Anilinobenzo(g)quinoline-3-carbonitrile",
      "4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile",
      "Bosulif",
      "SKI 606",
      "SKI-606"
    ]
  },
  "civic.tid:45": {
    "id": "civic.tid:45",
    "label": "Lapatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:480167"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C26653"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GSK572016",
      "GW 2016",
      "GW2016",
      "GW572016"
    ]
  },
  "civic.tid:52": {
    "id": "civic.tid:52",
    "label": "Neratinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1940643"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C49094"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(2E)-N-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
      "2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-",
      "HKI 272",
      "HKI-272",
      "PB 272",
      "PB-272"
    ]
  },
  "civic.tid:21": {
    "id": "civic.tid:21",
    "label": "Crenolanib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C64639"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C64639"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]-",
      "CP-868,596",
      "CP-868596",
      "PDGFR Inhibitor CP-868596",
      "[1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine"
    ]
  },
  "civic.tid:18": {
    "id": "civic.tid:18",
    "label": "TAE684",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C171615"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:66": {
    "id": "civic.tid:66",
    "label": "PI3K-alpha Inhibitor MEN1611",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C158603"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C158603"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5-(7-Methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine",
      "Alpha-selective PI3K Inhibitor MEN1611",
      "CH 5132799",
      "CH-5132799",
      "CH5132799",
      "MEN 1611",
      "MEN-1611",
      "MEN1611",
      "PA 799",
      "PA-799",
      "PA799",
      "PI3Kalpha Inhibitor MEN1611"
    ]
  },
  "civic.tid:67": {
    "id": "civic.tid:67",
    "label": "MTOR Inhibitor",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C2201"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C2201"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:473": {
    "id": "civic.tid:473",
    "label": "AGI-5198",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "iuphar.ligand:9240"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:241": {
    "id": "civic.tid:241",
    "label": "Lorlatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2103164"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C113655"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2H-4,8-Methenopyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-",
      "7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile",
      "Lorbrena",
      "PF-06463922"
    ]
  },
  "civic.tid:469": {
    "id": "civic.tid:469",
    "label": "Sirolimus",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:35302"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:37829",
              "type": "Disease",
              "label": "PEComa",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C38150"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1212"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,2",
      "AY 22989",
      "RAPA",
      "RAPAMYCIN",
      "Rapamune",
      "SILA 9268A",
      "WY-090217"
    ]
  },
  "civic.tid:124": {
    "id": "civic.tid:124",
    "label": "MTOR Kinase Inhibitor AZD8055",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C78856"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C78856"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD-8055",
      "AZD8055"
    ]
  },
  "civic.tid:505": {
    "id": "civic.tid:505",
    "label": "Quizartinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C68936"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C68936"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(2E)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3S)-Oxolan-3-Yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)but-2-Enamide",
      "AC-220",
      "AC010220",
      "AC220",
      "N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo [2,1-b] [1,3] Benzothiazol 2-yl]phenyl}urea"
    ]
  },
  "civic.tid:343": {
    "id": "civic.tid:343",
    "label": "Dactolisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C74072"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C74072"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "BEZ235",
      "Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-",
      "NVPBEZ235"
    ]
  },
  "civic.tid:541": {
    "id": "civic.tid:541",
    "label": "JQEZ5",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "iuphar.ligand:9332"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:55": {
    "id": "civic.tid:55",
    "label": "Ponatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1364347"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C95777"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AP-24534",
      "AP24534",
      "Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)"
    ]
  },
  "civic.tid:641": {
    "id": "civic.tid:641",
    "label": "Gilteritinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2105806"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C116722"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide",
      "ASP-2215",
      "ASP2215",
      "Xospata"
    ]
  },
  "civic.tid:260": {
    "id": "civic.tid:260",
    "label": "Lestaurtinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C48402"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C48402"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-",
      "CEP-701",
      "KT-5555",
      "SPM-924"
    ]
  },
  "civic.tid:9": {
    "id": "civic.tid:9",
    "label": "Fedratinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2197490"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C88293"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Benzenesulfonamide, N-(1,1-dimethylethyl)-3-((5-methyl-2-((4-(2-(1-pyrrolidinyl)ethoxy)phenyl)amino)-4-pyrimidinyl)amino)-",
      "SAR302503",
      "TG101348"
    ]
  },
  "civic.tid:17": {
    "id": "civic.tid:17",
    "label": "Alectinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1727455"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C101790"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-",
      "AF-802",
      "AF802",
      "ALK Inhibitor RO5424802",
      "Alecensa",
      "CH5424802",
      "RG7853",
      "RO5424802"
    ]
  },
  "civic.tid:23": {
    "id": "civic.tid:23",
    "label": "Motesanib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C71896"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C71896"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:24": {
    "id": "civic.tid:24",
    "label": "JAK2 Inhibitor AZD1480",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C91394"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C91394"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD-1480",
      "AZD1480"
    ]
  },
  "civic.tid:68": {
    "id": "civic.tid:68",
    "label": "Doxorubicin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:142433"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:675",
              "type": "Disease",
              "label": "Thyroid cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7510"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:569",
              "type": "Disease",
              "label": "Bladder cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9334"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:601",
              "type": "Disease",
              "label": "Gastric cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9331"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:614",
              "type": "Disease",
              "label": "Hodgkin lymphoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9357"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:666",
              "type": "Disease",
              "label": "Small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4917"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:667",
              "type": "Disease",
              "label": "Soft tissue sarcoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9306"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C456"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione",
      "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione",
      "14-Hydroxydaunomycin",
      "Adriablastin",
      "Hydroxydaunomycin",
      "Hydroxyl Daunorubicin",
      "Hydroxyldaunorubicin"
    ]
  },
  "civic.tid:274": {
    "id": "civic.tid:274",
    "label": "Patidegib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C80063"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C80063"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "FIN-5",
      "IP9 Free Base",
      "IPI-926",
      "IPI-926 Free Base",
      "Saridegib",
      "Smoothened Antagonist IPI-926"
    ]
  },
  "civic.tid:342": {
    "id": "civic.tid:342",
    "label": "Cobimetinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1722365"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C68923"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Cotellic",
      "GDC-0973",
      "MEK Inhibitor GDC-0973",
      "XL518"
    ]
  },
  "civic.tid:36": {
    "id": "civic.tid:36",
    "label": "PD173074",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "iuphar.ligand:5037"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:319": {
    "id": "civic.tid:319",
    "label": "AZD3463",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "iuphar.ligand:7706"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:30": {
    "id": "civic.tid:30",
    "label": "PLX4720",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "drugbank:DB06999"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:457": {
    "id": "civic.tid:457",
    "label": "Trastuzumab Emtansine",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1371041"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C82492"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ADO-TRASTUZUMAB EMTANSINE",
      "Ado Trastuzumab Emtansine",
      "Immunoglobulin G1, Anti-(Human P185neu Receptor) (Human-Mouse Monoclonal RhuMab HER2 Gamma1-Chain), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer, Tetraamide With N2'-(3-((1-((4-carboxycyclohexyl)methyl)-2,5-dioxo-3-pyrrolidinyl)thio)-1-oxopropyl)-N2'-deacetylMaytansine",
      "Kadcyla",
      "PRO132365",
      "RO5304020",
      "T-DM1",
      "Trastuzumab-DM1",
      "Trastuzumab-MCC-DM1",
      "Trastuzumab-MCC-DM1 Antibody-Drug Conjugate",
      "Trastuzumab-MCC-DM1 Immunoconjugate"
    ]
  },
  "civic.tid:465": {
    "id": "civic.tid:465",
    "label": "Canertinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C77588"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C77588"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-",
      "N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide"
    ]
  },
  "civic.tid:503": {
    "id": "civic.tid:503",
    "label": "Tandutinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C48404"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C48404"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1-Piperazinecarboxamide, 4-(6-Methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-",
      "CT53518",
      "MLN 518",
      "MLN518"
    ]
  },
  "civic.tid:568": {
    "id": "civic.tid:568",
    "label": "U0126",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "iuphar.ligand:5282"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:1629": {
    "id": "civic.tid:1629",
    "label": "FLT3/ABL/Aurora Kinase Inhibitor KW-2449",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C116858"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C116858"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "KW-2449"
    ]
  },
  "civic.tid:111": {
    "id": "civic.tid:111",
    "label": "Uprosertib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C84870"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C84870"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-Furancarboxamide, N-((1S)-2-Amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-",
      "GSK2141795",
      "Oral Akt Inhibitor GSK2141795"
    ]
  },
  "civic.tid:181": {
    "id": "civic.tid:181",
    "label": "Amrubicin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C80089"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C80089"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(+)-(7S,9S)-9-Acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)- 6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione"
    ]
  },
  "civic.tid:660": {
    "id": "civic.tid:660",
    "label": "Taselisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C116876"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C116876"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GDC-0032",
      "RO5537381"
    ]
  },
  "civic.tid:407": {
    "id": "civic.tid:407",
    "label": "Aromatase Inhibitor",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C1740"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1740"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:173": {
    "id": "civic.tid:173",
    "label": "Cytarabine",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:3041"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:575",
              "type": "Disease",
              "label": "CNS leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C5440"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C408"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      ".beta.-Cytosine Arabinoside",
      "1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone",
      "1-.beta.-D-Arabinofuranosylcytosine",
      "1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone",
      "1-Beta-D-arabinofuranosylcytosine",
      "1.beta.-D-Arabinofuranosylcytosine",
      "2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-",
      "2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-",
      "4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone",
      "ARA-cell",
      "Alexan",
      "Ara-C",
      "Arabine",
      "Arabinofuranosylcytosine",
      "Arabinosylcytosine",
      "Aracytidine",
      "Aracytin",
      "Aracytine",
      "Beta-Cytosine Arabinoside",
      "CHX-3311",
      "Cytarabinum",
      "Cytarbel",
      "Cytosar",
      "Cytosar-U",
      "Cytosine Arabinoside",
      "Cytosine-.beta.-arabinoside",
      "Cytosine-beta-arabinoside",
      "Erpalfa",
      "Starasid",
      "Tarabine PFS",
      "U 19920",
      "U-19920",
      "Udicil",
      "WR-28453"
    ]
  },
  "civic.tid:429": {
    "id": "civic.tid:429",
    "label": "Palbociclib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:1601374"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C49176"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one",
      "Ibrance",
      "PD 0332991",
      "PD 332991",
      "PD 991",
      "PD-0332991",
      "Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-"
    ]
  },
  "civic.tid:570": {
    "id": "civic.tid:570",
    "label": "Alpelisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "rxcui:2169285"
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C94214"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "BYL719",
      "Phosphoinositide 3-kinase Inhibitor BYL719",
      "Piqray"
    ]
  },
  "civic.tid:19830": {
    "id": "civic.tid:19830",
    "label": "PI-103",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "iuphar.ligand:5701"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:51": {
    "id": "civic.tid:51",
    "label": "Staurosporine",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_id",
        "value": "ncit:C1237"
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "ncit:C1237"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(9alpha,10beta,11beta,13alpha)-(+)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H-9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one",
      "8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-",
      "AM-2282",
      "Antibiotic 230",
      "Antibiotic AM 2282",
      "CGP-39360"
    ]
  }
}